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Over the past decade, various implantable devices have been developed to treat diseases that were
previously difﬁcult to manage such diabetes, chronic pain, and neurodegenerative disorders. However,
translation of these novel technologies into clinical practice is often difﬁcult because ﬁbrotic encapsu-
lation and/or rejection impairs device function after body implantation. Ideally, cells of the host tissue
should perceive the surface of the implant being similar to the normal extracellular matrix. Here, we
developed an innovative approach to provide implant surfaces with adhesive protein micropatterns. The
patterns were designed to promote adhesion of ﬁbroblasts and macrophages by simultaneously sup-
pressing ﬁbrogenic activation of both cell types. In a rat model, subcutaneously implanted silicone pads
provided with the novel micropatterns caused 6-fold lower formation of inﬂammatory giant cells
compared with clinical grade, uncoated, or collagen-coated silicone implants. We further show that
micropatterning of implants resulted in 2e3-fold reduced numbers of pro-ﬁbrotic myoﬁbroblast by
inhibiting their mechanical activation. Our novel approach allows controlled cell attachment to implant
surfaces, representing a critical advance for enhanced biointegration of implantable medical devices.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
The number of implanted medical devices such as pacemakers,
glucose sensors, and joint replacements prosthesis is steadily
increasing to address the needs of an aging population. These de-
vices dramatically improved the life of millions of patients world-
wide. However, in select applications such as diabetes and supportir and Regeneration, Matrix
ing, Room 234, University of
E2, Canada. Tel.: þ1 416 978
Surgery, Centre Hospitalier
Bugnon 46, 1011 Lausanne,
, gpietramaggiori@gmail.comof the central nervous system, sensors for continuous monitoring
and treatment of chronic conditions, clinical translation is
complicated due to foreign body reactions [1e8]. Depending on the
surface material, recipient site, and contact duration, implants
induce ﬁbrotic reactions that manifest clinically as scar-like cap-
sules around the device [3]. Fibrotic encapsulation not only reduces
the function and half-life of the device but can severely affect the
functionality of the host tissue in critical situations such as in-
fections, often requiring additional surgery for explantation, adding
risks for the patients and increasing the costs for the health care
system [9].
To improve implant device acceptance and function by reducing
foreign body and ﬁbrotic reactions, we need to understand the
mechanisms of tissueebiomaterial interactions. Several parameters
have been investigated to control foreign body reactions such as
functionalizationwith growth factors [10]. However, including such
biological clues in the implant material has not yet been sufﬁcient
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signaling molecules must follow a precisely controlled time and
concentration course in order to avoid a paradoxical down regu-
lation of speciﬁc receptors. Second, the biophysical properties of
the material is a powerful factor controlling the behavior of cells
such as terminal differentiation or activation, even overriding
speciﬁc actions of growth factors. Since controlling the orches-
trated expression of soluble molecules in vivo is a daunting if not
impossible task to date, we set out to manipulate the biophysical
properties of cell interactions with the extracellular matrix (ECM)
to guide cell behavior on the biomaterial surface. Our strategy
principally aims in controlling the activation of host-tissue resident
mesenchymal cells into myoﬁbroblasts in the peri-prosthetic
wound.
Myoﬁbroblasts are characterized by the neo-expression of a-
smooth muscle actin (a-SMA) and the excessive production of
collagen. It is the incorporation of a-SMA into microﬁlament bun-
dles (stress ﬁbers) that confers high cell contractile activity [11].
Myoﬁbroblast forces are transmitted to and perceived from the
ECM at sites of large, “supermature” focal adhesions (FA) that are
termed ‘ﬁbronexus’ in vivo [12e15]. FA mechanosensing is the basis
for spontaneous myoﬁbroblast activation upon adhesion to sufﬁ-
ciently rigid surfaces [11]. Since abnormal interaction of ﬁbroblasts
with implant surfaces is a possiblemajor cause for the development
of implant encapsulation, a variety of speciﬁc surface coatings have
been developed to improve biointegration [3,16], such as adding
Arg-Gly-Asp (RGD) sequences to mimic the integrin signaling
domain of ﬁbronectin. However, we hypothesize that the speciﬁc
size and distribution of the adhesion sites - rather than their sheer
presence in the substrate itself e is the key aspect to guide cell
attachment and behavior.
Using ﬁbroblast culture models, we have previously shown that
the size of FAs is directly proportional to the level of intracellular
tension and the activation state of myoﬁbroblasts. Formation of too
small FAs prevents ﬁbroblasts to attach and survive, formation of
too large FAs translates into excessive tension development and
ultimately myoﬁbroblast activation [17]. Here, we identiﬁed spe-
ciﬁc anti-ﬁbrotic protein micro-patterns and transferred them onto
silicone polymer surfaces in order to modulate celleimplant in-
teractions. To stably transfer cell-adhesive proteins with micro-
meter resolution onto compliant silicone substrates, we developed
an innovative stencil technology. Proteins are deposited in the
desired pattern through the openings of a stencil, produced by
photolithography. The principle of our novel implant surface
coating procedure is applicable to most implant materials and
shapes and we demonstrate that it is effective to suppress myoﬁ-
broblast and inﬂammatory cell activation at the surface of silicone
implants in cell culture and animal experiments.
2. Materials and methods
2.1. Cell culture and reagents
Primary rat ﬁbroblasts were explanted from subcutaneous tissue and used be-
tween passages P2 and P5 as described before [18] and cultured in standard Dul-
becco's modiﬁed Eagle's medium (DMEM; Life Technologies), supplemented with
10% fetal bovine serum (SigmaeAldrich), and penicillin/streptomycin (Life Tech-
nologies). Myoﬁbroblast activation was induced using 2 ng/ml TGF-b1 (R&D Sys-
tems, Abington, UK) added once for 5 days to the culture medium. Murine lineage
RAW 264.7 macrophages were cultured in standard medium and culture dishes.
Macrophages were activated by adding LPS for 7 days to cells grown on coated/
uncoated silicone substrates.
2.2. Hard stencil production
To create a ‘hard microstencil’ silicon mask, exhibiting arrays of openings with
characteristics of FAs at the bottom of a micro-reservoir, we used a silicon-on-
insulator (SOI) 380-2-50 wafer, dry etching, and soft lithography (Fig. 1a). Brieﬂy,
SOI wafer with the following dimensions have been used: upper silicon layer of
10 mm thickness, silicon oxide of 1 mm thickness and a lower silicon layer of 380 mmthickness. After cleaning the SOI with piranha solution, a 2 mm layer of oxide was
grown by wet oxidation. This layer served as a reinforcement mask for the photo-
resist during the etching processes. To create the microstructure bottom side of the
stencil we used a mask with small dimension holes and a 3 mm layer of AZ9260
photoresist. The mask pattern was transferred to the photoresist in a classical
photolithography step. To achieve a high aspect ratio for the holes, which was
recognized to be important for protein transfer, we applied an advanced dry etching
Bosch process. After etching, the photoresist was removed and thewafer was turned
to continue with the upper side's processing to generate the stencil reservoir. A
second photolithography step was then applied, using a 10 mm layer of the photo-
resist AZ9260 and a second mask to produce the wide opening of the reservoir. Dry
etching was again used to ﬁrst remove the silicon oxide and second to etch through
the thick silicon layer down to the interior oxide layer, serving to stop the etching
process. Finally, photoresist and oxide layer were removed using a wet etching
process to generate microstructure openings.
2.3. Pliable stencil production
To transfer proteins to curved surfaces that excluded close contact with the hard
stencil, we developed an alternative method to create ‘soft microstencils’ (Fig. 1b).
Brieﬂy, plasma oxygen cleaned silicon wafers were used as support to deposit a
10 mm thick layer of parylene C using a parylene deposition system (Comelec C-30-S,
La Chaux-de-Fonds, Switzerland). A second layer of 500 nm amorphous silicon (a-Si)
was deposed using a sputter (Pfeiffer SPIDER 600, Zürich, Switzerland), serving as
support for photoresist spin-coating. A photolithography step using a mask with
small dimension holes was then applied to 1 mm photoresist S1805. After devel-
opment of the photoresist, we applied a dry etching of a-Si layer using a silicon
etcher (Alcatel AMS 200 SE, Annecy, France) and dry etching Parylene C using (STS
Multiplex ICP). As terminal step, a-Si was stripped.
2.4. Silicone implants and protein deposition
Silicone pads consisting of clinical grade silicone (Silbione LSR4305, Silitech SA,
Gümligen, Germany) with dimensions 10  10  1 mm were either left uncoated
(control, corresponding to clinically used silicones) or covalently coated with
collagen type I (100 mg/ml, Devro Medical LTD, Glascow, UK), or human plasma
ﬁbronectin (FN, Sigma). To provide surfaces with a non-protein adhesive molecule,
we used poly N-acetyl glucosamine (sNAG, Marine Polymer Technologies, Inc.,
Burlington, MA, USA). For complete coating, collagen, FN, and sNAG were covalently
bound to silicone substrates, in consequent treatments with plasma oxygen, 3-
aminopropyltriethoxysilane (APTES) and glutaraldehyde [19,20] (Fig. 1c). In brief,
silicone surfaces were pre-treated with plasma oxygen (100 W, 300 mTorr, 45 s)
(Tepla, Kirchheim, Germany). This layer was then covalently provided with amine
groups by incubation with APTES (Sigma) (1% in water) and subsequent heating to
60 C for 60 min. Substrates were then copiously washed with PBS, immersed with
0.1% glutaraldehyde for 20 min, washed again 3-times with PBS and covalently
crosslinked with collagen for 60 min at 37 C [20]. For patterning, we exposed the
silicone surface to the same protein/sNAG functionalization procedure through a
silicon microstencil, exhibiting arrays of openings on the bottom of a micro-
reservoir with dimensions 2  2, 4  2, 6  2, 8  2, 10  2, and 20  2 mm, and
regular spacing of 5 mm. The stencil was removed to leaving the protein patterned
silicone (Fig. 1c). In one series of experiments, we used polycarbonate ﬁlters (Merck
Millipore, Tullagreen, Ireland) exhibiting pores with diameters of 2, 5 and 10 mm to
produce irregular patterns of adhesive islands. All protein-coated surfaces were
treated with PLL-g-PEG to prevent cell attachment any non-protein-coated regions
(passivation) as described before [17].
2.5. Antibodies, microscopy, and image analysis
For immunoﬂuorescence, we used primary antibodies directed against a-SMA
(aSM-1, a gift from Dr. G. Gabbiani, University of Geneva, CH), FN (Sigma), collagen
type I (Acris, San Diego, CA), F4/80 (BioLegend, San Diego, CA), CD68 (Abcam,
Cambridge, MA), and vinculin (hVin-1, Sigma). Primary antibodies were probedwith
AlexaFluor-conjugated goat anti-mouse, goat anti-rat, and goat anti-rabbit second-
ary antibodies (Molecular Probes, Invitrogen, Basel, CH). DNAwas probed with DAPI
(Sigma) and F-actin with Phalloidin-Alexa 488 (Molecular Probes) [21]. Phase
contrast and epiﬂuorescence microscopy was performed using oil immersion ob-
jectives (Plan-Neoﬂuar 40x/1.2 Ph3, Plan-Neoﬂuar 63x/1.4 Ph3, Zeiss) mounted on
an inverted microscope (Axiovert 135, Carl Zeiss AG, Feldbach, CH) and digital CCD
camera (Hamamatsu C4742-95-12ERG, Bucher Biotec AG, Basel, CH). Images were
acquired with Openlab 3.1.2 software (Improvision, Basel, CH) and assembled with
Adobe Photoshop CS5. To quantify the level of myoﬁbroblast activation, the per-
centages of a-SMA stress ﬁber-positive cells of all cells were quantiﬁed in a semi-
automated algorithm in Image J (U. S. National Institutes of Health (NIH),
Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997e2013). Macrophage fusion
into multi-nucleated giant cells was quantiﬁed by automatically detecting the
number of nuclei within the boundaries of F4/80-positive single cells. To exclude
that aggregates are quantiﬁed as single cells, macrophages were detached after 7
day growth on silicone surfaces, mechanically separated and reseeded onto standard
plastic dishes to be quantiﬁed after another 6 h. Mean values ± standard deviation
Fig. 1. Stencil microfabrication and silicone surface activation. (a) To create a ‘hard microstencil’ silicon mask, exhibiting arrays of openings with the characteristics of FAs at the
bottom of a micro-reservoir, we used SOI 380-2-50 wafer, dry etching, and soft lithography. A 2 mm layer of oxide ﬁrst was grown by wet oxidation, serving as a reinforcement mask
for the photoresist during the etching processes. The microstructure bottom side of the stencil was created by standard photolithography using a mask with small dimension holes
and a 3 mm layer of AZ9260 photoresist, followed by Bosch dry etching. The photoresist was then removed and the wafer turned to continue to generate the stencil reservoir in
another photolithographic step. Finally, photoresist and oxide layer were removed using a wet etching process to generate microstructure openings. (b) Soft microstencils were
designed to transfer proteins to curved surfaces. Silicon wafers were used as support to deposit a 10 mm thick layer of parylene C, followed by a second layer of 500 nm amorphous
silicon (a-Si). The a-SI served as support for spin-coating of an 1 mm-thick photoresist layer and subsequent photolithography through a mask bearing the micropattern. After
development of the photoresist, the a-Si and parylene layers were dry-etched and the a-Si was stripped in the terminal step. (c) For subsequent covalent binding of amine-
containing molecules (e.g., proteins and sNAG), silicone substrates were functionalized in consequent treatments using plasma oxygen, APTES and glutaraldehyde.
H. Majd et al. / Biomaterials 54 (2015) 136e147138(SD) were calculated from at least three independent experiments, each comprising
ten random regions of interest per experimental condition (~100 cells/ﬁeld).
2.6. Animal surgery and analysis of ﬁbrotic capsules
AdultmaleWistar strain rats (300e400 g) (n¼ 20) were fed a standard RM1 diet
(Nordos, Val de Reuil, France) and given water ad libitum. Each animal was subcu-
taneously implanted in the dorsal region with two uncoated implants, one
completely collagen coated implant, and one implant coated with arrays of 4 2 mm
islands, spaced 5 mm. The dimensions of the implants were 10  10  1 mm. Posi-
tions were randomly allocated and shifted in different animals on the dorsum of the
animals. After 30 days with the implant, rats were euthanized by carbon dioxide
after isoﬂurane anesthesia. The local ethics committee and veterinary authority
approved all procedures in accordance with Swiss guidelines. Implants were excised
in block with the surrounding tissue. Tissue samples were ﬁxed in 10% neutral-
buffered formalin, embedded in parafﬁn, sectioned, and stained with hematoxylin
and eosin (H&E) for histological analysis (Poly Scientiﬁc, Bay Shore, NY). For
immunoﬂuorescence staining of rat tissue, sections were deparafﬁnized in xylene,
rehydrated in ethanol, and rinsed in distilled water. Antigens were revealed by
boiling the slides in sodium citrate buffer (Dako, Burlington, ON) at 95e100 C for
40 min. After cooling to room temperature, sections were rinsed in PBS, blocked
with 2% goat serum/1% BSA for 40 min and stained with primary and secondary
antibodies.
The accumulation of multi-nucleated foreign body giant foam cells was quan-
tiﬁed in the central zone of the capsule on basis of H&E histological staining. Mas-
son's Trichrome staining was performed on parafﬁn-embedded sections to stain for
collagen. Myoﬁbroblasts were identiﬁed by staining for a-SMA as previously
described [22]. Brieﬂy, biotinylated a-SMA antibody (R&D Systems, Minneapolis,
MN)was applied to slides and incubated overnight at 4 C. Activationwas performed
with diaminobenzidine chromogen (DAB, Dako North America Inc., Carpinteria, CA)and counterstained with H&E. Total (Masson's Trichrome) and a-SMA positive
capsule thickness were quantiﬁed using image analysis (Morpho-Expert, Explora-
Nova, La Rochelle, France) on three different areas of the capsule from the implant
interface. Regions positive for collagen (blue in Trichrome Masson's staining) or for
myoﬁbroblasts (brown in a-SMA staining) were calculated as a percentage of the
whole area using Image J.3. Results
3.1. Production of stencils with FA microstructure and protein
deposition
Previously, we suppressed myoﬁbroblast activation on cell cul-
ture plastic and glass surfaces by restricting the length of FAs to
6 mm, using microprinting arrays of ECM protein islets [17].
Because microprinting of proteins is not efﬁcient for softer silicone
surfaces, e.g., such used in mammary implants, we developed a
novel micro-stencil technique to generate and covalently link
protein islets exhibiting FA features with lengths of 2, 4, 6, 8,10, and
20 mm and width of 2 mm (Fig. 1). Using photolithography, hard
silicon stencils were produced with arrays of openings in the
desired dimensions and spacing of 5 mmat the bottom of a reservoir
(Figs. 1a, 2aef). Pliable pyrelene stencils with the same array fea-
tures were developed to apply patterns to strongly curved substrate
surfaces (Figs. 1b, 2gei). Both processes delivered stencils with
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lution (Fig. 2def, hei).
To transfer proteins or the non-protein adhesivemolecule sNAG,
stencils were brought into conformal contact with silicone sub-
strates and the stencil reservoir ﬁlled with protein/sNAG solution
(Fig. 3a). In a series of preliminary experiments, we determined
that silicone surface functionalization for covalent binding of pro-
tein and sNAG in consequent treatments with plasma oxygen,
APTES, and glutaraildehyde [19,20] was pivotal for long-term sta-
bility of the coat (Fig. 1c). After removing the stencil, non-printed
regions of the hydrophobic silicone were additionally passivated
against cell attachment by immersing the substrate in protein-
repellent PLL-g-PEG [17]. The resulting patterns of ﬂuorescently
labeled deposited FN (Fig. 3b, c), collagen type I and sNAG (Fig. 3c)
accurately reproduced the printed structure. Primary rat subcu-
taneous ﬁbroblasts formed vinculin-positive FAs speciﬁcally and
exclusively where FN, collagen type I, and sNAGwere stenciled onto
the silicone in arrays of 4  2 mm and 20  2 mm islets (Fig. 3c).
Identical results were obtained using pliable pyrelene stencils
(unpublished data). FA formation of ﬁbroblasts was impaired by
growth on uncoated and extensive on completely coated silicones
(Fig. 3c).Fig. 2. Pliable and hard microstencils provide arrays of micron-resolution openings. (a) Micro
before cutting and (b) after cutting individual stencils with a side length of 1 cm. Scanning
stencil (c) at lowmagniﬁcation, (d) at high magniﬁcation for a 22 mm pattern and (e) 6  2 m
straight walls of the reservoir openings. Soft pyrelene microstencils with 4  2 mm patterns a
magniﬁcations.3.2. Microarrays of protein islands promote ﬁbroblast adhesion to
silicone and control phenotype
We next tested the efﬁcacy of ﬁbroblast adhesion to silicone
sample strips, stenciledwith adhesion island arrays. All FN-stenciled
surfaces promoted attachment of ﬁbroblasts in the absence
(Supplementary Fig. S1) and presence of ﬁbroblast-activating, pro-
ﬁbrotic TGF-b1 (Fig. 4a). Poor adhesion and cell spreading was
observed on uncoated silicone (Fig. 4a, Supplementary Fig. S1).
Quantifying the number of adherent ﬁbroblasts after 5 days (initial
seedingdensity: 75 cells/mm2)demonstrated that arrays of 42mm
FN islands were most efﬁcient to promote attachment and growth
(266 ± 21 cells/mm2) (Fig. 4b). Adhesion was signiﬁcantly higher
comparedwith control substrates thatwere completely coatedwith
FN (176 ± 16 cells/mm2). This attachment efﬁcacy was similar on FN
isletswith dimensions 10 2 mm(196± 5 cells/mm2) and 20 2 mm
(210 ± 22 cells/mm2) (Fig. 4b). Cell numbers on 2 2 mm islet arrays
(85 ± 3 cells/mm2) were low and comparable to those on uncoated
silicone substrates (106 ± 7 cells/mm2). On uncoated silicone sub-
strates,ﬁbroblasts didnot spread, remained spherical, and tended to
form aggregates that lifted off during the immunostaining proce-
dure (Fig. 4a, Supplementary Fig. S1).fabricated hard microstencils are demonstrated from the top on the ﬁnalized SOI wafer
electron micrographs demonstrate the microstructured openings at the bottom of the
m pattern from the top. (f) A tilted view on a 10  2 mm patterned stencil demonstrates
re demonstrated (g) on the wafer before cutting and (h, i) in micrographs with different
Fig. 3. Fibroblasts speciﬁcally attach to micro-stenciled protein patterns on silicone substrates. (a) Functionalized silicone surfaces (Fig. 1) were exposed to solutions of FN, collagen
type I, and sNAG through a silicon microstencil, exhibiting arrays of openings on the bottom of a micro-reservoir with dimensions 2  2, 4  2, 6  2, 8  2, 10  2, and 20  2 mm,
and regular spacing of 5 mm. (b) After removal of the stencil and passivation of non-printed regions with PLL-g-PEG, immunostaining for FN (green) revealed accurate reproduction
of the desired micropatterns. (c) Subcutaneous ﬁbroblasts grown for 5 days on substrates micro-patterned with ﬂuorescently labeled FN, collagen type I (Col) and sNAG (red),
formed FAs speciﬁcally with the printed islets, as shown by immunostaining for vinculin (green). On fully coated substrates, ﬁbroblasts formed FAs with various shapes and di-
mensions whereas no FAs were resolved on uncoated silicone. Scale bar: 20 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
H. Majd et al. / Biomaterials 54 (2015) 136e147140To assess the effect of silicone micropatterning on ﬁbroblast-to-
myoﬁbroblast activation, we quantiﬁed the percentage of rat sub-
cutaneous ﬁbroblasts expressing a-SMA in stress ﬁbers from
immunoﬂuorescence images (Fig. 4a). On silicone strips with
complete FN coating, spontaneous myoﬁbroblast activation was
14% (Supplementary Fig. S1, Fig. 4c). This fraction was signiﬁcantly
lower on 2  2 mm and 4  4 mm islet arrays (~2-fold) and uncoated
substrates (~3-fold), and was similar on 10 10 mmand 20 20 mm
patterns (Supplementary Fig. S1, Fig. 4c). Notably, formation of a-
SMA-negative stress ﬁbers was also reduced in cells grown on
2  2 mm patterns and stress ﬁbers were completely absent from
spherical cells on uncoated substrates (Supplementary Fig. S1). The
surface of silicone implants after surgery is exposed to an inﬂam-
matory environment containing high levels of circulating cell-
derived TGF-b1 [23]. Addition of TGF-b1 for 5d to the culture me-
dium decreased cell numbers by ~15% compared to the respective
substrate condition in the absence of TGF-b1 (unpublished data).
TGF-b1 induced an ~4-fold increase of the percentage of a-SMA-
positive cells on completely coated silicone, 10  2 mm, and
20  2 mm micropatterns (~60% a-SMA stress ﬁber-positive cells)
compared with TGF-b1-free medium (Fig. 4a, c). However, addition
of TGF-b1 only moderately increased the percentage of a-SMA
stress ﬁber-positive cells on 2  2 mm (~20%) and 4  2 mm (~30%)
micropatterns (Fig. 4a, c). Coatings produced with collagen type I
and sNAG delivered similar results than FN-coated substrates withrespect to cell numbers (Fig. 4d) and percentage of a-SMA-positive
cells (Fig. 4e).
To control whether systematic arrangement and shaping of
adhesive islets are required to affect ﬁbroblast adhesion and myo-
ﬁbroblast activation, we next produced irregular patterns of simi-
larly sized adhesive features. Silicone was stenciled with FN,
collagen, and sNAG through polycarbonate ﬁlters exhibiting
randomly arranged pores with diameters of 2, 5 and 10 mm (Fig. 5a).
Fibroblasts effectively attached and spread by forming FAs with the
protein islets and were activated by TGF-b1 to become a-SMA-
positive myoﬁbroblasts (~60%) even on small islet patterns
(Fig. 5bed). Collectively, these data demonstrate that regular arrays
of 4  2 mm adhesive islands allow for ﬁbroblast attachment and
proliferation by simultaneously suppressing a-SMA organization
into contractile ﬁbers. This effect was not achieved using uncoated
substrates that were found to be non-adhesive, and larger micro-
arrays and completely coated substrates that lead to substantial
myoﬁbroblast activation.
3.3. Microarrays of protein islets suppress monocyte/macrophage
fusion into giant foam cells
Foreign body reactions to silicone implants are initiated by the
recruitment and activation of macrophages to the implant surface.
One characteristic of an active inﬂammatory response and
Fig. 4. Proteinmicropatterns reduceﬁbroblast activation on silicone surfaces in vitro.Micropatterns of FNadhesion site islets of 2 2 mm,4 2 mm,10 2 mm, and 20 2 mmwere created
onsilicone substrates in addition to control non-coated () and fully coted silicone controls. Subcutaneousﬁbroblastswere culturedonall substrates for5days in thepresence andabsence
of pro-ﬁbrotic TGF-b1. (a) Fibroblast grown in the presence of TGF-b1were immunostained for a-SMA (blue), F-Actin (Phalloidin, green), and FN (red). (b) Fibroblasts density on different
FN-coated substrateswasquantiﬁedas cells permm2 fromnuclear countsafterDAPI-staining. (c) Thepercentageofa-SMA-positive cellswasquantiﬁedbysemi-automated image analysis
with andwithout TGF-b1 in the culturemedium. (d,e) The same analysiswas performedwith ﬁbroblasts grownon collagen type I and sNAG-coated silicone substrates. Scale bar: 100 mm.
Graphs show mean values from at least three independent experiments with error bars indicating SD. Data were analyzed using a Student's t-test against the respective full coated
condition and statistical signiﬁcance is indicated with * ¼ p < 0.01.
Fig. 5. Irregular micropatterns are ineffective in suppressing ﬁbroblast activation on silicones with small adhesive islands. (a) Polycarbonate ﬁlters exhibiting pores with diameters
of 2 mm, 5 mm, and 10 mm (phase contrast images) were used to produce irregular patterns of circular FN islands following the same procedure described for microstencils with
regular arrays. (b) Subcutaneous ﬁbroblasts were cultured on all substrates for 5 days in the presence of TGF-b1 and immunostained for a-SMA (blue), F-Actin (Phalloidin, green), FA
marker vinculin (red), and FN (white). Insets show magniﬁcations of single attachment sites Scale bar: 25 mm. (c) Fibroblasts densities on different substrates were quantiﬁed as
cells per mm2 from nuclear counts after DAPI-staining and (d) the percentage of a-SMA-positive cells was quantiﬁed by semi-automated image analysis. Graphs show mean values
from at least three independent experiments ± SD. Data were analyzed using a Student's t-test against values from fully coated silicone and statistical signiﬁcance is indicated with
* ¼ p < 0.01. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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cytes/macrophages into giant multi-nucleated cells during the
foreign body reaction [24,25]. To evaluate the effect of micro-
patterns on macrophage activation, we seeded F4/80-positive
murine macrophages onto uncoated, fully coated, and 4  2 mm
FN pattern-coated silicone strips for 7 days in the presence of
lipopolysaccharide (LPS). In contrast to ﬁbroblastic cells, macro-
phages did not form discrete vinculin-positive FAs (unpublished
data). Macrophages adhered with 2-fold higher numbers to fully FN
coated (387 ± 15 nuclei/mm2) and uncoated silicone substrates
(453 ± 18 nuclei/mm2) compared with 4  2 mm micro-patterned
surfaces (220 ± 17 nuclei/mm2) (Fig. 6a, b). Formation ofmultinuclear giant foam cells was highest on full FN-coated silicone
(86 ± 3% multi-nucleated cells) and lowest on micro-patterned
silicone (20 ± 4% multi-nucleated cells) (Fig. 6a, c). No differences
were observed between FN and collagen coating (unpublished
data).
3.4. Implant micropatterns reduce foreign body reactions and
ﬁbrotic capsule formation in vivo
Micropatterns of 4  2 mm islets of collagen, FN, and sNAG all
promoted adhesion of cultured ﬁbroblasts to silicone substrates
and suppressed myoﬁbroblast and macrophage activation. To
Fig. 6. Protein micropatterns reduce macrophage activation on silicone surfaces in vitro. FN was covalently linked to silicone surfaces as microstencilled micropatterns of 4  2 mm
adhesion site islets or as a full coat. Non-coated substrates () were used as control. (a) Macrophages were cultured on all substrates for 7 days in the presence of LPS and then
immunostained for the macrophage membrane marker F4/80 (green), FN (red), and DAPI (blue). (b) Macrophage density on differently coated substrates was quantiﬁed as nuclei
per mm2 from nuclear counts after DAPI-staining. (c) The percentage of multi-nucleated macrophages was quantiﬁed by semi-automated image analysis after cells have been
mechanically separated after 7d and reseeded at lower density for 6 h. Scale bar: 20 mm. Graphs show mean values from at least three independent experiments with error bars
indicating SD. Data were analyzed using a Student's t-test against the fully coated condition; statistical signiﬁcance is indicated with * ¼ p < 0.01. (For interpretation of the ref-
erences to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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subcutaneously implanted respectively coated/patterned silicone
strips subcutaneously to the dorsum of rats. As protein we used
collagen type I that is available in medical grade due to its weak
antigenicity and immunogenicity [26]. Uncoated silicone substrates
were used to represent the current clinical standard for implant
coating, and completely collagen coated silicone implants served as
positive experimental controls. When the body reaction to protein
patterned implants was histologically analyzed after 30 days
(Fig. 7a), accumulation of ECM and cells around micro-patterned
implants was substantially lower than in uncoated and fully
coated controls (Fig. 7bed). The center of capsules formed around
uncoated silicone implants was particularly rich in multi-nucleated
cells (6-fold compared to both other groups) which were identiﬁed
as foreign-body giant cells (Fig. 7b, inset) that stained positive for
the macrophage marker CD68 (Fig. 8a, green, arrows). Multi-
nucleated giant cells were virtually absent from capsules forming
around micro-patterned and fully coated implants (Fig. 7b) with
only few CD68-positive macrophages localizing to the
implantetissue interface (Fig. 8a, green, arrows). The collagenous
ECM organization and cellularity of capsules formed around micro-
patterned capsules was morphologically similar to the adjacent
normal connective tissue (Fig. 7a, b). In contrast, collagen coated
and uncoated implants were characterized by accumulation of
dense ECM ﬁbers and high cell density (Fig. 7b). To quantify the
thickness of the collagenous capsule wall surrounding the implant
we performed morphometric image analysis on cross-sections of
excised capsules with associated tissue that were stained with
Masson's Trichrome (Fig. 7c). The capsule wall diameter around
micro-patterned implants (37 ± 10 mm) was 3-times smaller than
the collagen rich layer around uncoated implants (50 ± 19 mm) and
1.5-times smaller than around fully coated implants (90 ± 37 mm)
(Fig. 7c).
Collagenous capsules always form around implants to various
degrees; it is the accumulation of contractile myoﬁbroblasts that
ultimately leads to ECM contracture and necessitates recurrent
surgery [27,28]. Immunostaining of tissue cross-sections for a-SMA
revealed that myoﬁbroblasts accumulated to different degrees
depending on the implant coating, being lowest in the micro-
patterned group (Fig. 8a). To quantify myoﬁbroblast occurrence,
cross-sections were immunohistochemically stained for a-SMA and
the thickness of the a-SMA-positive layer was measured from the
implant surface (Fig. 7d). The a-SMA positive layer at the surface of
micro-patterned implants was signiﬁcantly thinner (20 ± 7 mm)
than around completely coated implants (45 ± 18 mm) anduncoated implants (50 ± 21 mm) (Fig. 7d). This layer comprised
almost 90% of the total wall thickness around completely coated
implants but only ~50% of the capsule wall around micro-patterned
and uncoated implants. Analyzing the staining intensities of
collagen and a-SMA delivered similar results than those obtained
from measuring layer thickness (Fig. 8b). Collagen density in the
capsule was ~2-times lower (20 ± 4%) compared with capsules
formed around completely coated silicone (46.3 ± 19%) and ~3-
times lower than non-coated silicone implants (62.7 ± 15%)
(Fig. 8b). The density of a-SMA at the surface of micro-patterned
implants was generally low (22.3 ± 8%), in contrast to the cap-
sules of completely coated implants (46.6 ± 6%) and non-coated
implants (56 15%). Collagen and a-SMA densities in the capsule
layer were plotted against each other to provide a ‘capsule
contracture index’ (Fig. 8b) to show that 4  2 mm micropattern
signiﬁcantly reduce capsule formation and accumulation of con-
tractile myoﬁbroblasts in vivo.
4. Discussion
Avariety of different medical implants are produced with a shell
that is impermeable to cells, most often silicone or polyurethane,
which comes into contact with the patient's host tissue. Since
adverse reactions to silicone arise at the implant surface, recent
fundamental and clinical research focus on silicone shell engi-
neering to improve implant biointegration. In our study, we
developed a novel protein micropattern coating that improved
silicone implant biointegration by promoting: 1) decreased in-
ﬂammatory foreign body reaction, 2) controlled cell and ﬁbroblast
adhesion, and 3) decreased activation of a-SMA-positive myoﬁ-
broblasts (Fig. 9).
The formation of collagen-rich capsules around implants is part
of the normal wound healing response of inﬂammation, cell pro-
liferation, and tissue remodeling [3]. Material charge, wettability,
and topographic structure have a substantial impact on the adhe-
sive properties of silicone implants [29]. If implant materials are
non-adhesive for host cells and ECM, dead space develops between
the tissue and the implant surface, allowing non-speciﬁc absorp-
tion of blood plasma and serum proteins [3]. This chemical
microenvironment attracts and activates macrophages as impor-
tant sources of pro-ﬁbrotic cytokines, leading to ﬁbroblast
recruitment and myoﬁbroblast activation [30]. Conversely, adhe-
sive implants appear to partially reduce macrophage activation and
fusion into multi-nucleated giant cells during the foreign body re-
action [29]. Consistently, low-adhesive untreated silicones in our
Fig. 7. Micropatterning reduces contractile capsule formation around subcutaneously implanted silicone. Clinical grade silicone pads (10  10  1 mm) were left uncoated (),
covalently coated with collagen type I over the whole surface (collagen coated), and microstencilled with arrays of 4  2 mm adhesion patterns (42 collagen). Silicone pads were
then implanted subcutaneously on the dorsum of rats for 30 days before animals were sacriﬁced and the peri-silicone tissue was analyzed by histology. (a) H&E staining was used to
provide overall morphology and cellularity of the subcutaneous implant with its ECM- and cell-rich capsule, the underlying muscle layer, and the overlaying dermis and epidermis.
(b) Capsules forming around non-coated implants were populated by a higher numbers of multi-nucleated giant cells (outlined by dotted lines and arrows in higher magniﬁcation
inset) compared to completely coated and micro-patterned implants as seen in H&E stained tissue sections and respective quantiﬁcation giant multinuclear cells. (c) Masson's
trichrome staining was used to detect collagen rich ECM (blue) and to quantify the thickness of the collagenous ﬁbrotic layer from the implant surface. (d) Tissue sections were
immunohistochemically stained for a-SMA (brown) to identify myoﬁbroblast accumulation and the myoﬁbroblast layer thickness was quantiﬁed from the implant surface by image
analysis. Scale bars: (a): 1 mm, (bed): 100 mm. Quantiﬁcations were performed on at least 8 animals, each with four experimental conditions. Mean values are shown ± SD;
*p  0.01, two-tailed paired Student's t-test.
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compared to adhesive fully coated substrates in vivo and in vitro. It
is currently unclear, how 4  2 micro-patterned silicone surfaces
further suppress giant cell formation to ~20% of fully coated sili-
cone. However, other studies have shown that dictatingmacrophage shape and spreading by controlling substrate topog-
raphy is able to control the activation state of macrophages [31,32].
Despite reducing the macrophage-dominated foreign-body re-
action, highly adhesive silicone surfaces, such as the fully protein
coated silicones in our study, trigger severe ﬁbrotic capsule
Fig. 8. Micropatterned silicone implants produce a low ﬁbrotic proﬁle. Clinical grade silicone pads (10  10  1 mm) were left uncoated (), covalently coated with collagen type I
over the whole surface (collagen coated), and microstencilled with arrays of 4  2 mm adhesion patterns (4  2 collagen). Silicone pads were then implanted subcutaneously on the
dorsum of rats for 30 days before animals were sacriﬁced and parafﬁn sections of the peri-silicone tissue were produced. (a) Sections were immunoﬂuorescence-stained for
myoﬁbroblast marker a-SMA (red), macrophage marker CD68 (green), and nuclei (blue) and images were produced in two different magniﬁcations. Arrows point to CD68-positive
inﬂammatory cells. Scale bars: 100 mm. (b) To calculate a “ﬁbrotic index”, slides were immunohistochemically stained for either collagenous ECM (Masson's Trichrome) or myo-
ﬁbroblasts (a-SMA). The respective staining intensities were normalized to the total stained area using image analysis and plotted as collagen density over a-SMA density.
Quantiﬁcation was performed on at least 8 animals, each with four experimental conditions per experimental condition. Mean values are shown ± SD; *p  0.01, two-tailed paired
Student's t-test.
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myoﬁbroblasts is the main driver for ﬁbrogenesis and can occur
even at reduced levels of inﬂammation. A plethora of studies
demonstrated the spontaneous activation of various precursor cells
to attain the myoﬁbroblast phenotype on pathophysiologically stiff
polymer substrates [18,33e36]. Despite being macroscopically
deformable, implant silicone materials have a 100e1000-times
higher elastic modulus (~500e3000 kPa) than the connective
tissue of of recipient tissues like skin dermis [37,38] (~0.5e5 kPa).
Myoﬁbroblast activation is effectively suppressed by reducing
mechanical stress, either acting as extracellular stress in tissue
strain and stiffness or intracellularly as cell contraction [11].
Development of intracellular stress is limited by the amount of
force that ﬁbroblasts can transmit to any material, which can be
modulated by controlling substrate adhesiveness, deformability
(elastic modulus), or topography to promote cell spreading
[36,39e41]. In a previous study, we have shown that controlling the
size of individual FAs, i.e. the efﬁcacy of cell mechanosensing and
force transmission, controls intracellular stress and myoﬁbroblast
activation [17]. This effect was largely independent from island
density as shown by modulating island spacing from 2 to 6 mm.
However, a regular arrangement of FAs is pivotal becauseﬁbroblasts are able to extend single FAs over multiple small islands
that are closer than ~1.5 mm and accommodate cell morphology to
exert maximum tension. The size of FAs is linearly related to the
force they can transmit and sustainwith a stress of ~5.5 nN/mm2 for
classical FAs and ~12.5 nN/mm2 for myoﬁbroblast supermature FAs
[17,42]. Hence, restricting FAs size by micropatterning will limit the
tension developed by stress ﬁbers that are anchored to the ECM at
FAs. We have previously shown that high intracellular stress, in
turn, is required to promote myoﬁbroblast activation and incor-
poration of a-SMA into stress ﬁbers [17,21,37]. Once myoﬁbroblasts
are formed, they will contribute to collagen accumulation and
ﬁbrotic capsule contraction around the implant. For the present
study, we have selected micropattern arrays of 4  2 mm sized
adhesive structures that were shown to arrest ﬁbroblasts in a non-
contractile, non-ﬁbrotic state even on GPa-stiff plastic and glass
surfaces [17]. Transfer of these patterns to silicone implants was
sufﬁcient to supress myoﬁbroblast activation by 2e3-fold
compared to fully protein coated silicone pro-ﬁbrotic conditions in
culture and animal experiments.
Generation of protein patterns with micron-resolution on glass
and plastic is effective using microcontact printing [43e45]. How-
ever, to achieve good transfer, protein adhesion to the silicone
Fig. 9. Proposed mechanism of micropattern-suppressed capsular ﬁbrosis. Non-coated silicone implants are protein and cell-repellent, leading to an empty space that is ﬁlled by
inﬂammatory cells. Secretion of pro-ﬁbrotic cytokines by activated macrophages attract ﬁbroblasts and induce myoﬁbroblasts activation. Completely adhesive silicone implant
surface directly activate myoﬁbroblasts by providing a mechanical stimulus. Micropatterned silicone surfaces provide a balance of sufﬁcient cell and ECM adhesion without me-
chanically activating ﬁbroblastic and inﬂammatory cells resulting in a reduced capsule thickness.
H. Majd et al. / Biomaterials 54 (2015) 136e147146rubber stamp has to be lower than the afﬁnity to the substrate. This
is difﬁcult to achieve when both substrate and stamp are fabricated
with the same silicone material and similar mechanical properties.
We here solved this critical limitation of former techniques by
developing an innovative microstencil method to covalently attach
soluble adhesive compounds, including proteins onto silicone
substrates with ~1 mm resolution. Using pliable pyrelene stencils,
we are further able accommodate curved and three-dimensionally
complex surfaces. One open remaining question is whether the
anti-ﬁbrotic effect of the novel micropattern observed after 1 week
in culture and after 4 weeks in animal experiments will last in long-
term clinical applications. Preliminary results at one year show a
stable tissue reaction around the implants (not shown) and a
number of studies suggest that early activation of myoﬁbroblasts
already sets the stage for a persistent ﬁbrotic reaction. This effect is
partly due to the speciﬁc chemical and mechanical property of
myoﬁbroblast-derived ECM [46,47] and partly due to the ability of
myoﬁbroblast populations to retain and propagate once acquired
features in a changed environment [48].
In summary, our results suggest that uncoated silicone induces
the formation of a ﬁbrotic capsule containing a high number of
contractile myoﬁbroblasts, probably as a result of lack of cell
adhesion and macrophage activation via foreign body reaction.
Completely coated silicone surfaces have similar ﬁbrotic effects
because unrestricted cell attachment sites cause highmyoﬁbroblast
development possibly via intracellular mechanical forces devel-
opment on the implant surface during healing. The identiﬁed novelmethods to generate micropatterns on silicone substrates sup-
pressed the dead space and decreased foreign body reaction, while
also having an anti-ﬁbrotic effect due to the speciﬁc design
(4  2 mm) of the adhesion sites.
5. Conclusions
In conclusion, we have developed a novel strategy to make sil-
icone surfaces more biocompatible. This micro-patterning
approach has several advantages compared to previously pro-
posed techniques including the possibility to being applied to
several different biomaterials without changing their macroscopic
properties and being based entirely on clinically used substrates.
These experimental results will hopefully set the stage for clinical
translation in the near future.
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